MaaT Pharma
A clinical-stage biotech developing microbiome-based therapeutics for oncology.
MAAT | PA
Overview
Corporate Details
- ISIN(s):
- FR0012634822 (+1 more)
- LEI:
- 969500CQQB6XUNW6CN97
- Country:
- France
- Address:
- 70 AVENUE TONY GARNIER, 69007 LYON
- Website:
- https://www.maatpharma.com/
Description
MaaT Pharma is a clinical-stage biotechnology company specializing in the development of microbiome-based therapeutics. The company's primary focus is on oncology, aiming to improve survival outcomes for cancer patients by modulating the immune system through the gut microbiome. It develops Microbiome Ecosystem Therapies (MET) designed to restore gut microbiome symbiosis. The company's pipeline includes product candidates for treating complications in patients with blood cancers and solid tumors, with its lead candidate, MaaT013, in late-stage development for acute Graft-versus-Host Disease (aGvHD). MaaT Pharma utilizes an AI-powered platform for drug development and has its own cGMP manufacturing capabilities.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-15 10:41 |
Franchissement de seuils
|
French | 108.0 KB | ||
| 2025-12-08 18:00 |
Inside Information / Other news releases
|
English | 139.6 KB | ||
| 2025-12-08 18:00 |
Informations privilégiées / Autres communiqués
|
French | 145.6 KB | ||
| 2025-11-21 11:22 |
Franchissement de seuils
|
French | 107.2 KB | ||
| 2025-11-14 23:05 |
Inside Information / Operations of the issuer (acquisitions, sales...)
|
English | 121.9 KB | ||
| 2025-11-14 23:05 |
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
|
French | 176.1 KB | ||
| 2025-11-13 19:40 |
Inside Information / Other news releases
|
English | 193.4 KB | ||
| 2025-11-13 19:40 |
Informations privilégiées / Autres communiqués
|
French | 156.5 KB | ||
| 2025-11-05 07:30 |
Inside Information / Other news releases
|
English | 162.7 KB | ||
| 2025-11-05 07:30 |
Informations privilégiées / Autres communiqués
|
French | 132.6 KB | ||
| 2025-11-04 07:30 |
Inside Information / News release on accounts, results
|
English | 109.1 KB | ||
| 2025-11-04 07:30 |
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 167.6 KB | ||
| 2025-11-03 18:00 |
Inside Information / Other news releases
|
English | 150.3 KB | ||
| 2025-11-03 18:00 |
Informations privilégiées / Autres communiqués
|
French | 163.0 KB | ||
| 2025-10-13 14:47 |
Franchissement de seuils
|
French | 106.3 KB |
Automate Your Workflow. Get a real-time feed of all MaaT Pharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for MaaT Pharma
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for MaaT Pharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-07-12 | N/A | Other | Sell | 8 | 60.87 EUR |
| 2024-07-11 | N/A | Other | Sell | 57 | 436.14 EUR |
| 2023-12-22 | N/A | Other | Buy | 2,940 | 14,994.00 EUR |
| 2023-12-22 | N/A | Other | Buy | 1,960 | 9,996.00 EUR |
| 2023-09-27 | N/A | Other | Buy | 500 | 3,050.00 EUR |
Peer Companies
